Tingyan Shi Selected Research

Microgels

6/2023

Minimally invasive injection of biomimetic Nano@Microgel for in situ ovarian cancer treatment through enhanced photodynamic reactions and photothermal combined therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tingyan Shi Research Topics

Disease

12	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 10/2015
10	Neoplasms (Cancer) 03/2024 - 10/2015
6	Ovarian Epithelial Carcinoma 01/2021 - 10/2015
2	Disease Progression 01/2021 - 01/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2017 - 01/2015
2	Rectal Neoplasms (Rectal Cancer) 11/2015 - 01/2015
1	Hyperthermia 03/2024
1	Neutropenia 01/2021
1	Ascites 01/2021
1	Photosensitivity Disorders (Photodermatitis) 01/2021
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 09/2020
1	Carcinoma (Carcinomatosis) 09/2020
1	Fallopian Tube Neoplasms 09/2020
1	Endometrial Neoplasms (Endometrial Cancer) 03/2019
1	Genomic Instability 01/2017
1	Carcinogenesis 10/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Diarrhea 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 05/2013

Drug/Important Bio-Agent (IBA)

5	PlatinumIBA 01/2022 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2015
2	niraparibIBA 01/2022 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 01/2015
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 03/2024
1	Drug CombinationsIBA 03/2024
1	Cleavage And Polyadenylation Specificity FactorIBA 11/2023
1	BoronIBA 11/2023
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 06/2023
1	MicrogelsIBA 06/2023
1	Oxygen (Dioxygen)IBA 06/2023
1	Photosensitizing Agents (Photosensitizers)IBA 06/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023
1	Chimeric Antigen ReceptorsIBA 01/2021
1	Zn(II)-phthalocyanine (zinc phthalocyanine)IBA 01/2021
1	cyanogenIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	AntigensIBA 01/2021
1	SulfadimethoxineIBA 01/2021
1	RacivirIBA 09/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	exodeoxyribonuclease IIBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 11/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015
1	Interleukin-1 (Interleukin 1)IBA 11/2015
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 10/2015
1	ParaffinIBA 01/2015
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Myeloid Cell Leukemia Sequence 1 ProteinIBA 01/2015
1	Plasminogen Activator Inhibitor 1IBA 01/2015
1	Apoptosis Regulatory ProteinsIBA 01/2015
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2015
1	AndrogensIBA 05/2013
1	3-Oxo-5-alpha-Steroid 4-Dehydrogenase (Testosterone 5 alpha Reductase)IBA 05/2013
1	SteroidsIBA 05/2013

Therapy/Procedure

7	Therapeutics 03/2024 - 10/2015
6	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
2	Cytoreduction Surgical Procedures 01/2022 - 01/2020
2	Immunotherapy 01/2021 - 03/2019
2	Neoadjuvant Therapy 09/2020 - 10/2015
2	Radiotherapy 03/2019 - 01/2015
1	Induced Hyperthermia (Thermotherapy) 03/2024
1	Hyperthermic Intraperitoneal Chemotherapy 03/2024
1	Photochemotherapy (Photodynamic Therapy) 06/2023
1	Intravenous Administration 06/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Operative Time 10/2017
1	Hysterectomy 10/2017
1	Catheters 10/2017
1	Chemoradiotherapy 11/2015